Trial · NCT03333928
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Absolute Change in Serum Alkaline Phosphatase (ALP) From Baseline to Week 6 in Period 1 | Baseline to Week 6 | |
| Secondary | Percentage of Subjects Who Achieve ALP of <1.5 x ULN at the End of Week 6 (Period 1) | Baseline to Week 6 | |
| Secondary | Percentage of Subjects Who Achieve a 50% Decrease in ALP at the End of Week 6 (Period 1) | Baseline to Week 6 | |
| Secondary | Percentage of Subjects Who Normalize ALP at the End of Week 6 (Period 1) | Baseline to Week 6 | |
| Secondary | Absolute Change in Serum Total Bilirubin at the End of Week 6 (Period 1) | Baseline to Week 6 | |
| Secondary | Absolute Change in Serum ALP From Week 6 to Week 12 (Period 2) | Week 6 to Week 12 | |
| Secondary | Percentage of Subjects Who Achieve ALP of <1.5 x ULN at the End of Week 12 (Period 2) | Week 6 to Week 12 | |
| Secondary | Percentage of Patients Who Achieve a 50% Decrease in ALP at the End of Week 12 (Period 2) | Week 6 to Week 12 | |
| Secondary | Percentage of Patients Who Normalize ALP at the End of Week 12 (Period 2) | Week 6 to Week 12 | |
| Secondary | Absolute Change in Serum Total Bilirubin at the End of Week 12 (Period 2) | Week 6 to Week 12 | |
| Secondary | Absolute Change in Serum ALP From Week 12 to Week 18 (Period 3) | Week 12 to Week 18 | Change in serum ALP between a new baseline at Week 12 and the final value at Week 18 for all subjects following the randomized withdrawal |
| Secondary | Percentage of Patients Who Achieve ALP of <1.5 x ULN at the End of Week 18 (Period 3) | Week 12 to Week 18 | The percentage of patients who achieve ALP of \<1.5 x ULN at the end of week 18 (Period 3) |
| Secondary | Percentage of Patients Who Achieve a 50% Decrease in ALP at the End of Week 18 (Period 3) | Week 12 to Week 18 | |
| Secondary | Percentage of Subjects Who Normalize ALP at the End of Week 18 (Period 3) | Week 12 to Week 18 | |
| Secondary | Absolute Change in Serum Total Bilirubin at the End of Week 18 (Period 3) | Week 12 to Week 18 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03333928/registered